tiprankstipranks
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
Holding MRSN?
Track your performance easily

Mersana Therapeutics (MRSN) Financial Statements

442 Followers

Mersana Therapeutics Financial Overview

Mersana Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.613; its P/E ratio is -3.62; Mersana Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 12.60M$ 2.29M$ 9.24M$ 10.70M$ 7.70M
Gross Profit$ 12.60M$ 2.29M$ 9.24M$ 10.70M$ 7.70M
EBIT$ -11.10M$ -24.30M$ -18.30M$ -18.50M$ -40.64M
EBITDA$ -10.70M$ -22.78M$ -17.88M$ -18.05M$ -40.21M
Net Income Common Stockholders$ -11.50M$ -24.27M$ -19.31M$ -19.54M$ -41.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.87M$ 59.00M$ 75.19M$ 174.56M$ 186.28M
Total Assets$ 169.53M$ 179.13M$ 198.37M$ 226.06M$ 262.90M
Total Debt$ 31.50M$ 32.31M$ 33.08M$ 33.63M$ 34.34M
Net Debt$ -47.36M$ -26.69M$ -42.11M$ -140.93M$ -151.94M
Total Liabilities$ 168.48M$ 170.70M$ 170.39M$ 189.16M$ 210.71M
Stockholders Equity$ 1.05M$ 8.43M$ 27.95M$ 36.90M$ 52.20M
Cash Flow-
Free Cash Flow$ -8.58M$ -21.86M$ -32.79M$ -32.35M$ -46.55M
Operating Cash Flow$ -8.58M$ -21.86M$ -32.66M$ -31.96M$ -46.08M
Investing Cash Flow$ 28.47M$ 5.51M$ -72.55M$ 20.15M$ 103.78M
Financing Cash Flow$ -23.00K$ 153.00K$ 5.83M$ 92.00K$ -146.00K
Currency in USD

Mersana Therapeutics Earnings and Revenue History

Mersana Therapeutics Debt to Assets

Mersana Therapeutics Cash Flow

Mersana Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis